Quick Answer
DocGo Inc. reported Research And Development Expense of $13.56 million for the year ending 2025.
- DocGo Inc. showed an increase of +17.0% in Research And Development Expense from 2024 to 2025.
- This data is from DocGo Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $569.4 thousand | Q2 2021: $664.9 thousand | Q3 2021: $854.6 thousand | Q1 2022: $1.14 million | Q2 2022: $1.15 million | Q3 2022: $1.37 million | Q1 2023: $1.86 million | Q2 2023: $2.57 million | Q3 2023: $3.24 million | Q1 2024: $2.39 million | Q2 2024: $2.37 million | Q3 2024: $3.15 million | Q1 2025: $3.64 million | Q2 2025: $2.96 million | Q3 2025: $3.19 million.
- Over the full 6 years of available data (2020 to 2025), DocGo Inc.'s Research And Development Expense has grown by 1,040.2%.
- Historical annual values: Fiscal year 2025: $13.56 million | Fiscal year 2024: $11.59 million | Fiscal year 2023: $10.86 million | Fiscal year 2022: $5.38 million | Fiscal year 2021: $3.32 million | Fiscal year 2020: $1.19 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: